On 2025-05-13, Ovid Therapeutics (OVID) announced earnings per share of $-0.14 for the fiscal quarter ending 2025-03-31, meeting the average analyst estimate of $-0.14.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.16 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.14 | $-0.14 |
| 2025-03-11 | 2024-12-31 | $-0.16 | $-0.13 |
| 2024-11-12 | 2024-09-30 | $-0.19 | $-0.20 |
| 2024-08-13 | 2024-06-30 | $-0.22 | $0.12 |
| 2024-05-14 | 2024-03-31 | $-0.23 | $-0.17 |
| 2024-03-08 | 2023-12-31 | $-0.17 | $-0.22 |
| 2023-11-03 | 2023-09-30 | $-0.18 | $-0.16 |
| 2023-08-04 | 2023-06-30 | $-0.21 | $-0.18 |
| 2023-05-05 | 2023-03-31 | $-0.18 | $-0.19 |
| 2023-03-13 | 2022-12-31 | $-0.19 | $-0.16 |
| 2022-11-08 | 2022-09-30 | $-0.21 | $-0.17 |
| 2022-08-09 | 2022-06-30 | $-0.23 | $-0.21 |
| 2022-05-10 | 2022-03-31 | $1.17 | $-0.23 |
| 2022-03-15 | 2021-12-31 | $-0.17 | $-0.38 |
| 2021-11-10 | 2021-09-30 | $-0.19 | $-0.17 |
| 2021-08-16 | 2021-06-30 | $-0.15 | $-0.23 |
| 2021-05-13 | 2021-03-31 | $1.32 | $2.53 |
| 2021-03-15 | 2020-12-31 | $-0.31 | $-0.34 |
| 2020-11-12 | 2020-09-30 | $-0.43 | $-0.28 |
| 2020-08-10 | 2020-06-30 | $-0.38 | $-0.41 |
| 2020-05-07 | 2020-03-31 | $-0.34 | $-0.37 |
| 2020-03-11 | 2019-12-31 | $-0.46 | $-0.35 |
| 2019-11-08 | 2019-09-30 | $-0.37 | $-0.43 |
| 2019-08-07 | 2019-06-30 | $-0.49 | $-0.34 |
| 2019-05-07 | 2019-03-31 | $-0.48 | $-0.46 |
| 2019-03-07 | 2018-12-31 | $-0.55 | $-0.52 |
| 2018-11-08 | 2018-09-30 | $-0.59 | $-0.53 |
| 2018-08-09 | 2018-06-30 | $-0.59 | $-0.53 |
| 2018-05-08 | 2018-03-31 | $-0.48 | $-0.54 |
| 2018-03-29 | 2017-12-31 | $-0.39 | $-0.45 |
| 2017-11-09 | 2017-09-30 | $-0.60 | $-0.38 |
| 2017-08-10 | 2017-06-30 | $-0.39 | $-0.57 |
| 2017-06-13 | 2017-03-31 | $-0.64 | $-3.48 |